Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Finance symbols : Nvsef save search
IMPORTANT ALERT: Halper Sadeh LLC Investigates KDNY, FRG, ARNC
Published: 2023-07-03 (Crawled : 22:00) - prnewswire.com
APO | $107.63 0.31% 0.0% 2.2M
|
Finance
| Email alert
Add to watchlist
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
| Email alert
Add to watchlist
RILY | News | $20.04 1.47% 1.45% 810K
|
Finance
| Email alert
Add to watchlist
ARNC | $29.99 0.03% 0.0% 0
|
Non-Energy Minerals
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
FRG | $29.88 0.1% 0.1% 0
|
Commercial Services
| Email alert
Add to watchlist
IMPORTANT ALERT: Halper Sadeh LLC Investigates FOCS, KDNY, PTEN, FRG
Published: 2023-06-27 (Crawled : 08:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.01%
H: 0.16%
C: -0.32%
NEX | $10.61 0.75% 17M
|
Industrial Services
|
| O: 0.23%
H: 2.3%
C: 1.03%
PTEN 4 | $11.51 1.5% 1.48% 4.7M
|
Industrial Services
|
| O: -0.43%
H: 3.41%
C: 2.33%
FRG | $29.88 0.1% 0.1% 0
|
Commercial Services
|
| O: 0.07%
H: 0.0%
C: -0.31%
FOCS | $52.99 -0.02% -0.04% 6.8M
|
Finance
|
| O: 0.0%
H: 0.17%
C: 0.1%
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: 0.26%
H: 0.53%
C: 0.1%
RILY | News | $20.04 1.47% 1.45% 810K
|
Finance
|
| O: 1.09%
H: 3.71%
C: 3.57%
Alimera Appoints Roger Sawhney, M.D. to Its Board of Directors
Published: 2023-02-27 (Crawled : 16:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.64%
H: 0.01%
C: -0.72%
KKR | $92.62 -0.78% 0.0% 4.5M
|
Finance
|
| O: 1.6%
H: 0.75%
C: -0.47%
ALIM | $3.41 -0.87% -0.88% 48K
|
Health Technology
|
| O: 0.22%
H: 1.98%
C: -2.25%
Global Digital Respiratory Devices Market Report to 2030 - Featuring Cohero Health, Cognita Labs, Adherium, Amiko Digital Health and Teva Pharmaceuticals Industries Among Others
Published: 2023-02-13 (Crawled : 00:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.27%
H: 0.42%
C: -0.21%
EHTH | $4.485 -2.71% -2.79% 240K
|
Finance
|
| O: -0.22%
H: 2.99%
C: 2.33%
pharmaceuticals global report health teva respiratory market
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT2606, a Proposed Biosimilar of Nucala® (mepolizumab) Bio-Thera Solutions, Ltd. announced that dosing has begun in a Phase I cli...
Published: 2022-10-14 (Crawled : 13:00) - biospace.com/
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.17%
H: 0.8%
C: -0.75%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -2.63%
H: 2.37%
C: -2.5%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.93%
H: 0.0%
C: 0.0%
DVA | $127.82 1.36% 0.0% 490K
|
Health Services
|
| O: 0.65%
H: 1.88%
C: -0.77%
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 0.4%
H: 1.39%
C: -0.3%
UTHR | $237.99 0.45% 0.45% 400K
|
Health Technology
|
| O: 0.24%
H: 1.71%
C: 1.01%
NNVC | $1.1 -6.38% 0.0% 22K
|
Health Technology
|
| O: 2.34%
H: 0.0%
C: 0.0%
bat2606 nucala solutions biosimilar study
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.